In addition to the mechanisms underlying the dual role of the GPX2 gene in tumorigenesis and proliferation remaining unclear for some cancers, the association of this gene with increased drug resistance may also be a challenge for its use as a new cancer treatment target, particularly regarding its observed association with increased cisplatin resistance. The gene discussed is GPX2; the disease is cancer.